業績集 1996
2011 | 2010 |
2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 |
1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993
| 1 | Masunaga S., Ono K., Mitsumori M., Nishimura Y., Hiraoka M., Akuta K., Nagata Y., Abe M., Takahashi M., Jo S.: Clinical usefulness of determining the rate of thermal clearance within heated tumors., Jpn J Clin Oncol, 26(6): 428-37, 1996 |
|
| 2 | Mitsumori M., Hiraoka M., Okuno Y., Nishimura Y., Y.P. Li, Fujishiro S., Nagata Y., Abe M., Koishi M., Sano T., Marume T., Takayama N.: A phase I and II clinical trial of a newly developed ultrasound hyperthermia system with an improved planar transducer., Int J Radiat Oncol Biol Phys, 36(5): 1169-75, 1996 |
|
| 3 | Mitsumori M., Hiraoka M., Shibata T., Okuno Y., Nagata Y., Nishimura Y., Abe M., Hasegawa M., Nagae H., Ebisawa Y.: Targeted hyperthermia using dextran magnetite complex: a new treatment modality for liver tumors., Hepatogastroenterology, 43(12): 1431-7, 1996 |
|
| 4 | Mizowaki T., Nagata Y., Okajima K., Murata R., Yamamoto M., Kokubo M., Hiraoka M., Abe M.: Development of an MR simulator: experimental verification of geometric distortion and clinical application., Radiology, 199(3): 855-60, 1996 |
|
| 5 | Mizowaki T., Nishimura Y., Shimada Y., Nakano Y., Imamura M., Konishi J., M. Hiraoka: Optimal size criteria of malignant lymph nodes in the treatment planning of radiotherapy for esophageal cancer: evaluation by computed tomography and magnetic resonance imaging., Int J Radiat Oncol Biol Phys, 36(5): 1091-8, 1996 |
|
| 6 | Murata R., Nishimura Y., Shibamoto Y., Hiraoka M., Abe M.: Changes in cell proliferative parameters of SCCVII and EMT6 murine tumors after single-dose irradiation., Jpn J Cancer Res, 87(6): 662-8 ,1996 |
|
| 7 | Murata R., Shibamoto Y., Miyauchi S., Hirohashi M., Takagi T., Sasai K., Oya N., Hiraoka M.: The combined antitumour effect of a new 5-fluorouracil derivative, BOF- A2, and radiation in vivo., Br J Cancer Suppl, 27: S114-6, 1996 |
|
| 8 | Nagata Y., Okajima K., Murata R., Mitsumori M., Mizowaki T., Yamamoto M., Hiraoka M., Nishidai T., Nakata M. , Abe M., Sugahara K., Arimura H., Hosoba M., Morisawa H., Kazusa C., Ai D., Kokubo M.: Development of an integrated radiotherapy network system., Int J Radiat Oncol Biol Phys, 34(5): 1105-11, 1996 |
|
| 9 | Nishimura Y., Murata R., Hiraoka M.: Combined effects of an angiogenesis inhibitor (TNP-470) and hyperthermia., Br J Cancer, 73(3):270-4 , 1996 |
|
| 10 | Nishimura Y., Nagata Y., Okajima K., Mitsumori M., Hiraoka M., Masunaga S., Ono K., Shoji K., Kojima H.: Radiation therapy for T1,2 glottic carcinoma: impact of overall treatment time on local control., Radiother Oncol, 40(3): 225-32, 1996 |
|
| 11 | Shibata T., Shibamoto Y., Sasai K., Oya N., Murata R., Takagi T., Hiraoka M., Abe M.: Comparison of in vivo efficacy of hypoxic cytotoxin tirapazamine and hypoxic cell radiosensitizer KU-2285 in combination with single and fractionated irradiation., Jpn J Cancer Res, 87(1): 98-104 , 1996 |
|
| 12 | Ishikura S., Mitsumori M., Hiraoka M.: Clinical results of breast conserving therapy for stage I and II breast cancers: assessment of local recurrence in relation to surgical margins., Int. J. Clin. Oncol., 1: 170-75, 1996 |
|
| 13 | Shibata T., Shibamoto Y., Sasai K., Oya N., Murata R., Takagi T., Hiraoka M. , Takahashi M., Abe M.: Tirapazamine: hypoxic cytotoxicity and interaction with radiation as assessed by the micronucleus assay., Br J Cancer Suppl, 27: S61-4, 1996 |
|
| 14 | Harauchi H., Umeda T., Inamura K., Teshima T., Inoue T., Hishikawa Y., Ando Y., Fukuhisa K., Nagata Y., Okajima K., Murakami M.: Initial Data-element Selection and its Feasibility for the Development of a Multi-institutional Radiation Oncology Database., J. Jpn. Soc. Ther. Radiol. Oncol., 8: 335-45, 1996 |